On October 24, 2019, Yu, Henry; Clark, Michael; Bemis, Guy; Boyd, Michael; Chandupatla, Kishan; Collier, Philip; Deng, Hongbo; Dong, Huijun; Dorsch, Warren; Hoover, Russell R.; Johnson, Mac Arthur, Jr.; Kukarni, Shashank; Penney, Marina; Ronkin, Steven; Takemoto, Darin; Tang, Qing; Waal, Nathan D.; Wang, Tiansheng published a patent.Recommanded Product: 1227002-03-0 The title of the patent was Preparation of substituted oxazepanyl pyrimidinamines as antiproliferation compounds. And the patent contained the following:
The present invention provides compounds I [ring A = Ph, 5-7 membered saturated or partially unsaturated carbocyclic ring, 8-12 membered saturated or partially unsaturated bicyclic heterocyclic ring having 1-2 heteroatoms independently selected from N, O, or S, etc.; each R1 = (independently) H, or (halo)alkyl; or two R1 groups are optionally taken together with their intervening atoms to form 5-8 membered partially unsaturated fused carbocyclic ring; each of R2 = (independently) H, halo, CN, etc.; or two R2 groups are optionally taken together to form :O; or two R2 groups are optionally taken together with their intervening atoms to form 3-8 membered saturated spirocyclic ring having 0-2 heteroatoms independently selected from N, O or S; each R3 = (independently) H, OH, or alkyl; or two R3 groups are optionally taken together to form :O or :CH2; or two R3 groups are optionally taken together with their intervening atoms to form 3-8 membered saturated spirocyclic ring having 0-2 heteroatoms independently selected from N, O or S; or 5-8 membered saturated bridged bicyclic ring having 0-2 heteroatoms independently selected from N, O or S; X = O, S, CH2, etc.; m = 0-2; n = 0-5; p = 0-2] or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer). E.g., a multi-step synthesis of (R)-II and (S)-II, starting from 3-(tributylstannylmethoxy)propan-1-amine and 2-chloro-5-nitrobenzaldehyde, was described. Exemplified compounds I were evaluated in the Colo 205 reporter assay, HepG2 XBP1 reporter assay, and in the Calcium Flux assay (data given for representative compounds I). The experimental process involved the reaction of Methyl 2-amino-5-chloroisonicotinate(cas: 1227002-03-0).Recommanded Product: 1227002-03-0
The Article related to oxazepanyl pyrimidinamine preparation antiproliferative antitumor, Heterocyclic Compounds (More Than One Hetero Atom): Other 7-Membered Rings and other aspects.Recommanded Product: 1227002-03-0